AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledDecember 29th, 2017 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 1, 2018 (the “Effective Date”), between Richard Wright, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).